CORD-19:8c51cf0cc444f6a851ad178040369984759ddfec / 5674-5866 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/8c51cf0cc444f6a851ad178040369984759ddfec","sourcedb":"CORD-19","sourceid":"8c51cf0cc444f6a851ad178040369984759ddfec","text":"Multicenter studies should be initiated to share sera and clinical information in order to determine if antibody profiles can be used as a marker to start, continue, and discontinue treatment.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T49","span":{"begin":0,"end":192},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T49","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"Epistemic_Statements","denotations":[{"id":"T25","span":{"begin":0,"end":192},"obj":"Epistemic_statement"}],"attributes":[{"subj":"T25","pred":"source","obj":"Epistemic_Statements"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T49","span":{"begin":0,"end":192},"obj":"Sentence"}],"attributes":[{"subj":"T49","pred":"source","obj":"CORD-19_Custom_license_subset"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93ecce","default":true},{"id":"Epistemic_Statements","color":"#ecb493"},{"id":"CORD-19_Custom_license_subset","color":"#9a93ec"}]}]}}